Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

AbbVie blood cancer combo therapy fails in late-stage study

Ruchika Sharma2 Oct 2023 1:00 PM IST

United States: AbbVie has said a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully...

Viatris, Ocuphire Pharma get USFDA nod for Ryzumvi for treatment of Pharmacologically-Induced Mydriasis

Ruchika Sharma2 Oct 2023 11:30 AM IST

Pittsburgh: Viatris Inc., a global healthcare company, and Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on...

Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitis

Phase 3 Mariposa study evaluating Rybrevant plus Lazertinib meets primary endpoint in PFS in Non-Small Cell Lung Cancer: Janssen

Ruchika Sharma2 Oct 2023 10:00 AM IST

Rartan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 MARIPOSA study...

Eli Lilly settles whistleblower lawsuit over manufacturing problems

Ruchika Sharma1 Oct 2023 4:30 PM IST

United States: Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out...

Granules India inaugurates two advanced Centres of Excellence at IIT Hyderabad

Granules India bags USFDA nod for Losartan and Hydrochlorothiazide Tablets

Ruchika Sharma1 Oct 2023 2:30 PM IST

Hyderabad: Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug...

Novo Nordisk Wegovy approved by USFDA for adults with noncirrhotic MASH with liver fibrosis

Novo Nordisk eyes to bring blockbuster weight-loss drug Wegovy to India in 2026

Ruchika Sharma1 Oct 2023 1:00 PM IST

Novo charges more than $1300 in the U.S. for a monthly supply and about 300 euros ($317) a month in Germany.

Glenmark inks pact to market Cosmo Pharma acne treatment Winlevi in Europe, South Africa

Ruchika Sharma1 Oct 2023 11:30 AM IST

Mumbai: Cosmo Pharmaceuticals N.V. and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. have announced the signing of...

Mylab Discovery Solutions introduces MyNeoShield for New born Screening

Ruchika Sharma1 Oct 2023 10:30 AM IST

Pune: Mylab Discovery Solutions has announced a ground-breaking advancement in new-born screening (NBS) with the introduction of its...

Sun Pharma Told to Revise Delafloxacin Phase III Trial Protocol

Sun Pharma to buy out local partner Indi Pharma from Mexican arm for over Rs 75 crore

Ruchika Sharma30 Sept 2023 3:30 PM IST

New Delhi: Sun Pharmaceutical Industries Ltd on Thursday said it will buy out local partner Indi Pharma from its Mexican arm for MXN 161.85 million...

Aurobindo Pharma arm Eugia Pharma B.V incorporates new wholly owned subsidiary in Chile

Aurobindo Pharma gets 1 USFDA observation for Sangareddy facility

Ruchika Sharma30 Sept 2023 1:30 PM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued 1 observation after the...

Zydus gets CDSCO permission to begin PCSK9 inhibitor Phase I clinical study

Ruchika Sharma30 Sept 2023 12:30 PM IST

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that it has received permission from CDSCO, India to initiate the...

Merck Sotatercept for pulmonary arterial hypertension gets USFDA priority review

Ruchika Sharma30 Sept 2023 11:00 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok